Showing results (2611-2620 of 3,164) with videos related to

Sort By:
Pageof 317
Neuro-Oncology|September 1, 2025
Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular AnalysesYolanda Piña, Vincent Law, Solmaz Sahebjam, et al.
Neuro-Oncology|August 29, 2025
Distinct and Reproducible Neurocognitive Profiles in Stable Diffuse Glioma: A Data-Driven Approach to Understanding Cognitive HeterogeneityMaxine Gorter, Jantine G Röttgering, Vera Belgers, et al.
Neuro-Oncology|September 3, 2025
Spatial profiling of longitudinal glioblastoma reveals consistent changes in cellular architecture, post-treatmentShoaib Ajaib, Joshua Winter-Luke, Richard J Digby, et al.
Neuro-Oncology|August 20, 2016
Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivorsErika Roddy, Katherine Sear, Erin Felton, et al.
Neuro-Oncology|October 25, 2019
Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasisSuresh K Balasubramanian, Mayur Sharma, Vyshak A Venur, et al.
Neuro-Oncology|July 25, 2015
The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with gliomaJanine M Lupo, Annette M Molinaro, Emma Essock-Burns, et al.
Neuro-Oncology|July 18, 2015
Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohortJohan Pallud, Etienne Audureau, Georges Noel, et al.
Neuro-Oncology|July 17, 2015
Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patientsLarry A Harshyne, Brian J Nasca, Lawrence C Kenyon, et al.
Neuro-Oncology|July 2, 2015
From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Norbert Galldiks, Karl-Josef Langen, Whitney B Pope
Neuro-Oncology|July 2, 2015
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastomaKathryn M Field, John Simes, Anna K Nowak, et al.
Pageof 317